- An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. Viscoli, C., Herbrecht, R., Akan, H., Baila, L., Sonet, A., Gallamini, A., Giagounidis, A., Marchetti, O., Martino, R., Meert, L., Paesmans, M., Ameye, L., Shivaprakash, M., Ullmann, A.J., Maertens, J. J. Antimicrob. Chemother. (2009)